rewirebio.iobenchmarks
Dataset

COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)

COLO829 tumour reads only, PacBio HiFi Revio, 60.7x, used at 50x.

Evaluation results

8 evaluations · 56 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.137 AUPRC (indel only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'AUPRC'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.2 F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'F1-score'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
377 False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'FN'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
1,482 False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'FP'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.136 Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'Precision'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.382 Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'Recall'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
233 True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'TP'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.558 AUPRC (SNV only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'AUPRC'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.653 F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'F1-score'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
5,855 False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'FN'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
29,409 False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'FP'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.53 Precision (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'Precision'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.85 Recall (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'Recall'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
33,231 True positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'TP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.189 AUPRC (indel only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'AUPRC'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.262 F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'F1-score'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
308 False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'FN'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
1,396 False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'FP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.178 Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'Precision'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.495 Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'Recall'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
302 True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'TP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.644 AUPRC (SNV only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'SNV', column 'AUPRC'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.785 F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'SNV', column 'F1-score'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
2,901 False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'SNV', column 'FN'
Configuration: ClairS-TO SS v0.4.0, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
16,917 False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'SNV', column 'FP'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

21 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Assay
PacBio HiFi Revio WGS, pbmm2 to GRCh38
Context-only references
ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2025-10-31; PMC12579226 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 6b5e5262df96467010d539e919c7a52aac3e49c616b3eeb403d1865dcb173b8a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
PacBio HiFi Revio WGS, pbmm2 to GRCh38
Context-only references
ClairS-TO Source Data workbook

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Source Data file (41467_2025_64547_MOESM6_ESM.xlsx) of the published article
Retrieved: 2026-10-11T21:38:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 4347c74fe0ce2ed04b1ac40d28bd4f8885c77f628e911a7027a275b1234828f8

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
PacBio HiFi Revio WGS, pbmm2 to GRCh38
Context-only references
ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines)

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information PDF (41467_2025_64547_MOESM1_ESM.pdf) of the published article
Retrieved: 2026-10-11T21:37:53Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 806cd47423031495bf00543d7e3e3abad3f93fc4ee3ee2a7a570c335227f5603

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
One cancer cell line, tumour sample only (no matched normal used by the callers)
Context-only references
ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2025-10-31; PMC12579226 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 6b5e5262df96467010d539e919c7a52aac3e49c616b3eeb403d1865dcb173b8a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
One cancer cell line, tumour sample only (no matched normal used by the callers)
Context-only references
ClairS-TO Source Data workbook

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Source Data file (41467_2025_64547_MOESM6_ESM.xlsx) of the published article
Retrieved: 2026-10-11T21:38:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 4347c74fe0ce2ed04b1ac40d28bd4f8885c77f628e911a7027a275b1234828f8

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
One cancer cell line, tumour sample only (no matched normal used by the callers)
Context-only references
ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines)

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information PDF (41467_2025_64547_MOESM1_ESM.pdf) of the published article
Retrieved: 2026-10-11T21:37:53Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 806cd47423031495bf00543d7e3e3abad3f93fc4ee3ee2a7a570c335227f5603

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Truth: NYGC COLO829 somatic truth (42,993 SNVs, 985 indels before filtering); a truth variant is kept only if coverage is at least 4, at least 3 reads support the alternative allele and VAF is at least 0.05
Context-only references
ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2025-10-31; PMC12579226 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 6b5e5262df96467010d539e919c7a52aac3e49c616b3eeb403d1865dcb173b8a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Truth: NYGC COLO829 somatic truth (42,993 SNVs, 985 indels before filtering); a truth variant is kept only if coverage is at least 4, at least 3 reads support the alternative allele and VAF is at least 0.05
Context-only references
ClairS-TO Source Data workbook

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Source Data file (41467_2025_64547_MOESM6_ESM.xlsx) of the published article
Retrieved: 2026-10-11T21:38:10Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 4347c74fe0ce2ed04b1ac40d28bd4f8885c77f628e911a7027a275b1234828f8

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Truth: NYGC COLO829 somatic truth (42,993 SNVs, 985 indels before filtering); a truth variant is kept only if coverage is at least 4, at least 3 reads support the alternative allele and VAF is at least 0.05
Context-only references
ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines)

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information PDF (41467_2025_64547_MOESM1_ESM.pdf) of the published article
Retrieved: 2026-10-11T21:37:53Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 806cd47423031495bf00543d7e3e3abad3f93fc4ee3ee2a7a570c335227f5603

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a
Context-only references
ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling

Original source ↗

Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Communications, published 2025-10-31; PMC12579226 full-text XML
Retrieved: 2026-10-11T21:37:39Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 6b5e5262df96467010d539e919c7a52aac3e49c616b3eeb403d1865dcb173b8a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-clairs-to-20261011-data-pacbio-colo829

areas
dna-genomes
contexts
clinical_research
population
One cancer cell line, tumour sample only (no matched normal used by the callers)
assay
PacBio HiFi Revio WGS, pbmm2 to GRCh38
split
Held out from ClairS-TO training (SS: synthetic HG001/HG002 or HG003/HG004; SSRS: plus HCC1937, HCC1954, H1437 and H2009)
scope note
Truth: NYGC COLO829 somatic truth (42,993 SNVs, 985 indels before filtering); a truth variant is kept only if coverage is at least 4, at least 3 reads support the alternative allele and VAF is at least 0.05
source locator
Results 'Benchmarking datasets and evaluation' paragraph 1; Supplementary Table 1a
missing metadata
version: reason: unreported; note: Data releases are named by provider only
Related records

Suggest a correction